Novo Holdings acquisition highlights growing pharma commercialization service market, says managing partner

Although it had made several investments in the clinical service market, this is the first time Novo Holdings has ventured into commercialization territory.
Photo: Novo Holdings / PR
Photo: Novo Holdings / PR
by albert rønning-andersson, translated by catherine brett

The smoke had barely lifted from the New Year fireworks when Novo Holdings announced its first acquisition of 2022 – US company Medical Knowledge Group (MKG).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading